Disease | multiple myeloma |
Comorbidity | C1332362|b-cell neoplasm |
Sentences | 1 |
PubMedID- 22404949 | Although the clinical outcome of plasma cell myeloma when concomitant with other indolent b-cell neoplasms is unfavorable, our patient seemed to respond to high-dose bortezomib plus lenalidomide. |
Page: 1